Literature DB >> 1837475

Myelopathies in the cancer patient: incidence, presentation, diagnosis and management.

A K Choucair1.   

Abstract

Last month, the author discussed epidural spinal cord compression. This month he describes the incidence, clinical presentation, and management of CNS complications from intradural, extramedullary metastases; leptomeningeal carcinomatosis; intramedullary spinal cord metastasis; paraneoplastic myelopathies; radiation myelopathy, and chemo-induced myelopathy.

Entities:  

Mesh：

Year:  1991        PMID： 1837475

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


  5 in total

Review 1.  Pure intramedullary spinal cord metastasis secondary to gastric cancer.

Authors:  Roberto Gazzeri; Marcelo Galarza; Andrea Faiola; Giovanni Gazzeri
Journal:  Neurosurg Rev       Date:  2006-02-08       Impact factor: 3.042

2.  Intramedullary spinal cord metastasis from colonic carcinoma presenting as Brown-Séquard syndrome: a case report.

Authors:  Mohammed A Kaballo; Darren D Brennan; Mazen El Bassiouni; Stephen J Skehan; Rajnish K Gupta
Journal:  J Med Case Rep       Date:  2011-08-02

3.  Prophylactic enlargement of the thecal sac volume by spinal expansion duroplasty in patients with unresectable malignant intramedullary tumors and metastases prior to radiotherapy.

Authors:  Ingo Fiss; C Bettag; B Schatlo; K von Eckardstein; I Tsogkas; A Schwarz; C von der Brelie; V Rohde
Journal:  Neurosurg Rev       Date:  2018-11-14       Impact factor: 3.042

Review 4.  Intramedullary Spinal Cord Tumors: Part I-Epidemiology, Pathophysiology, and Diagnosis.

Authors:  Dino Samartzis; Christopher C Gillis; Patrick Shih; John E O'Toole; Richard G Fessler
Journal:  Global Spine J       Date:  2015-03-31

Review 5.  Intramedullary Spinal Cord Tumors: Part II-Management Options and Outcomes.

Authors:  Dino Samartzis; Christopher C Gillis; Patrick Shih; John E O'Toole; Richard G Fessler
Journal:  Global Spine J       Date:  2015-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.